Navigation Links
Autism Tests for Preemies May Be Faulty, Study Suggests
Date:5/2/2011

By Amanda Gardner
HealthDay Reporter

SUNDAY, May 1 (HealthDay News) -- Doctors are erroneously diagnosing autism spectrum disorder in many 18-month-old toddlers who were born extremely premature, a small new study suggests.

Later testing showed that a high proportion of the toddlers diagnosed with autism spectrum disorder at that age were not autistic, the researchers found. Instead, the youngsters simply had a cognitive or language delay, both of which are common in children who were preterm babies, the researchers said.

Part of the problem, the researchers suggested, is that children who were premature may be undergoing testing for autism too early in life.

"We need to continue to watch these kids very closely, keeping in mind that they're at high risk for multiple, different kinds of developmental difficulties and delays, but not necessarily jumping to the conclusion that this is definitely autism at such an early age," said study lead author Dr. Bonnie Stephens.

"We need to monitor them over time, knowing we may not be able to diagnosis them [accurately] until they're a little bit older," added Stephens, a neonatologist and developmental and behavioral pediatrician at Women & Infants Hospital of Rhode Island.

Many neonatal specialists follow the recommendation of the American Academy of Pediatrics that all children aged 18 to 24 months should be screened for autism spectrum disorder. Those who score below-average on the test are then referred for more diagnostic testing.

Stephens said rates of autism are on the rise in the United States and, "there seemed to be higher rates in the extremely preterm population. The first couple of studies showed rates that were higher than seemed possible and these studies were coming out right after the AAP recommendation."

But many things can go wrong in the early life of preterm infants, such as language and cognitive delays, Stephens said.

"We bet that ... there might be a lot of false-positives," she added.

That hypothesis turned out to be correct -- at least in this small study sample of infants born prematurely at Stephens' hospital and monitored for the first 30 months of their lives. Babies in the study had been born before 28 weeks of gestation and were assessed for autism spectrum disorder using three different tests at 18 months and 30 months of age (with the ages corrected for prematurity).

At the first assessment, 18 percent of 152 toddlers tested positive for autism spectrum disorder, but at 30 months, only 10 percent of 116 youngsters did.

"We saw a significant decrease in positive screens," said Stephens, who stressed that the findings were preliminary and that follow-up research is continuing with her team planning a larger trial.

As it turned out, only 3 percent of the youngsters failed all three screening tests at both 18 months and 30 months of age. Later testing showed these children did end up being diagnosed with autism spectrum disorder.

But toddlers who tested positive on some screens for autism spectrum disorder at both 18 and 30 months of age did have cognitive and language delays, Stephens said.

"Early diagnosis is important, but we were becoming concerned that a high rate of false-positives had at least the potential to cause unnecessary stress for parents. In this group of [premature] kids, we followed them so closely they all got early intervention anyway [for other problems]," Stephens said. "We felt that the early identification of a positive screen may not be as critical as making an accurate diagnosis."

Stephens was scheduled to present the findings Sunday at the annual meeting of the Pediatric Academic Societies, in Denver. Research presented at such meetings should be viewed as preliminary because it hasn't undergone scrutiny similar to studies published in peer-reviewed journals.

The study findings run counter to one trend in autism spectrum disorder research these days, which is that being born early may be a risk factor for autism, said Cynthia Johnson, director of the Autism Center at the Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center.

Taken together, she said, "this speaks to the lack of our measures being sensitive enough to differentiate preemies who may end up having some cognitive differences in language but [ones] not specific to autism."

"Deferring a diagnosis makes sense. Sometimes we have to do a little more wait-and-see," Johnson said. "I think if providers are suspicious of an autism diagnosis, it warrants mentioning to families. These families know their children are at risk for a number of things, not just autism, and the science is not where we can be more definitive right now."

More information

The March of Dimes has more on premature babies.

SOURCES: Bonnie E. Stephens, M.D., assistant professor, pediatrics, Warren Alpert Medical School, Brown University, and staff neonatologist and developmental and behavioral pediatrician, Women & Infants Hospital of Rhode Island, Providence; Cynthia Johnson, Ph.D., director, Autism Center, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center; May 1, 2011, presentation, Pediatric Academic Societies annual meeting, Denver


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Quick Screening May Help Spot Autism in Babies
2. Social bonding in prairie voles helps guide search for autism treatments
3. Catching signs of autism early: The 1-year well-baby check-up approach
4. New data shows half of all children with autism wander and bolt from safe places
5. Many With Autism Also Have Treatment-Resistant Epilepsy: Study
6. Treatment-resistant epilepsy common in idiopathic autism
7. Having Both Autism and Epilepsy Linked to Raised Death Rates
8. Mortality rate is increased in persons with autism who also have epilepsy
9. Autism Speaks awards $770,000 for gastrointestinal research in autism spectrum disorders
10. Best Places to Live With Autism All in Major Metro Areas: Survey
11. Autism Diagnoses Still More Likely in Richer Neighborhoods
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... A man who has struggled to quit smoking, a man who has struggled with hair ... solutions to his problems – and he did. Now Nabat, a serial entrepreneur featured as ... breakthrough inventions to the world and better people's lives. His own experience with nicotine addiction ...
(Date:2/8/2016)... ... 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving the ... has teamed up with Citizens Opposed to Domestic Abuse in support of its efforts ... all those victimized by the fear of violence in their own homes, donations may ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... Discover the Rocky Mountain region’s longest running and ... companies. Attendees also get to see the most incredible gardens and home improvement ... , at the Colorado Convention Center - 700 14th St. Denver CO, is an ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua ... on how healthcare companies can use newly released government data on populations and ... population and intervene and capture the value they create to succeed in new ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Company, Inc. (NYSE MKT: AXN) today announced that for the ... the Company achieved revenue of $8,195,839, a 27% improvement on ... 2015. --> --> The ... $2,068,635, or $.03 per share, up 265% from the net ... of fiscal year 2015. Gross margin for the three months ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
(Date:2/8/2016)... Calif. , Feb. 8, 2016  Sangamo ... in therapeutic genome editing, announced that the U.S. ... Company,s Investigational New Drug (IND) application for SB-318, ... life-long therapy for Mucopolysaccharidosis Type I (MPS I). ... enables Sangamo to initiate a Phase 1/2 clinical ...
Breaking Medicine Technology: